NEW YORK, April 3, 2024 /PRNewswire/ — The global digital twin market size is estimated to grow by USD 32784.18 mn from 2023 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 39.92% during the forecast period. North America held the largest share of the global…
Month: April 2024
With Over Three Decades of Experience Working with Nonprofits, Private Companies, and Elected Officials, Suzanna Valdez Wolfe Steps in to Accelerate SHPE’s Transformational Growth and Community Impact CITY OF INDUSTRY, Calif., April 3, 2024 /PRNewswire/ — SHPE (Society of Hispanic…
PANAMA CITY, April 3, 2024 /PRNewswire/ — Copa Holdings, S.A. (NYSE: CPA) announces the following events: Earnings Release – First Quarter 2024 Date: May 15, 2024 Time: After US market close This release will be available on our website:…
PANAMA CITY, April 3, 2024 /PRNewswire/ — Copa Holdings, S.A. (NYSE: CPA) announces the following events: Earnings Release – First Quarter 2024 Date: May 15, 2024 Time: After US market close This release will be available on our website:…
LG Energy Solution invites Arizona state government and local community officials for a construction progress update on its second U.S. stand-alone facility Completion and start of production expected in about two years, with full-scale hiring for thousands of new jobs to begin in the…
LG Energy Solution invites Arizona state government and local community officials for a construction progress update on its second U.S. stand-alone facility Completion and start of production expected in about two years, with full-scale hiring for thousands of new jobs to begin in the…
NEW YORK, April 3, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of agilon health, inc. (NYSE: AGL): (i) pursuant and/or traceable to the offering documents issued in connection with the Company’s May 2023 secondary public…
NEW YORK, April 3, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of agilon health, inc. (NYSE: AGL): (i) pursuant and/or traceable to the offering documents issued in connection with the Company’s May 2023 secondary public…
Treatment will be Marketed by Nobelpharma Co. Ltd. Under the Trade Name Sargmalin® PMDA Approval of Sargmalin is the first regulatory approval of an inhaled recombinant GM-CSF product for aPAP LEXINGTON, Mass., April 3, 2024 /PRNewswire/ — Partner Therapeutics, Inc. (PTx) announced that…
Treatment will be Marketed by Nobelpharma Co. Ltd. Under the Trade Name Sargmalin® PMDA Approval of Sargmalin is the first regulatory approval of an inhaled recombinant GM-CSF product for aPAP LEXINGTON, Mass., April 3, 2024 /PRNewswire/ — Partner Therapeutics, Inc. (PTx) announced that…